Lymphedema After Axillary Lymph Node Dissection in Breast Cancer: Prevalence and Risk Factors-A Single-Center Retrospective Study

被引:22
|
作者
Hara, Yuki [1 ]
Otsubo, Ryota [1 ]
Shinohara, Shota [1 ]
Morita, Michi [2 ]
Kuba, Sayaka [2 ]
Matsumoto, Megumi [1 ]
Yamanouchi, Kosho [2 ]
Yano, Hiroshi [1 ]
Eguchi, Susumu [2 ]
Nagayasu, Takeshi [1 ]
机构
[1] Nagasaki Univ, Dept Surg Oncol, Grad Sch Biomed Sci, Nagasaki, Japan
[2] Nagasaki Univ Hosp, Dept Surg, Nagasaki, Japan
关键词
axillary lymph node dissection; axillary reverse mapping; breast cancer; lymphedema; REVERSE MAPPING ARM; ADJUVANT; CHEMOTHERAPY; ASSOCIATION; SURVIVORS;
D O I
10.1089/lrb.2021.0033
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Lymphedema may develop when axillary lymph node dissection (ALND) injures and obstructs the lymph ducts in the upper limb. In patients with breast cancer, lymphedema is difficult to treat and can cause arm swelling, heaviness, and restricted movement. We aimed to identify the prevalence and risk factors for lymphedema after ALND in patients with breast cancer.Methods and Results: This retrospective study included 175 patients with breast cancer who underwent ALND in the Nagasaki University Hospital, Japan, between 2005 and 2018. Lymphedema was defined as symptomatic arm swelling with a >2-cm difference in the arm circumference between the affected and contralateral arms. Patients were divided into two groups according to the presence or absence of lymphedema. Surgical and pathological findings were compared between the two groups. Univariate and multivariate analyses were performed, including the chi-square test, Student's t-test, and logistic regression analysis. Lymphedema was prevalent in 20% of the study participants, and the mean time interval from surgery to development of lymphedema was 479 days. In the univariate analysis, a body mass index of >26 kg/m(2), smoking, radiotherapy (RT), and dissection of >18 axillary lymph nodes (ALNs) significantly increased the risk of lymphedema. In the multivariate analysis, smoking, RT, and dissection of >18 ALNs significantly increased the risk of lymphedema.Conclusions: The prevalence of lymphedema in our study was 20%. Our findings suggest that smoking, RT, and dissection of >18 ALNs are risk factors for lymphedema. Aggressive and empiric ALND might be associated with axillary lymph duct damage.
引用
收藏
页码:600 / 606
页数:7
相关论文
共 50 条
  • [1] Prevalence and risk factors associated with development of lymphedema after axillary lymph node dissection among breast cancer patients: Single center retrospective study
    Hara, Y.
    Otsubo, R.
    Inamasu, E.
    Matsumoto, M.
    Yano, H.
    Sakimura, C.
    Kuba, S.
    Yamanouchi, K.
    Eguchi, S.
    Nagayasu, T.
    CANCER RESEARCH, 2019, 79 (04)
  • [2] A case control study on risk factors of lymphedema after axillary lymph node dissection for breast cancer in Hong Kong
    Mak, S.
    Yeo, W.
    Mo, K. F.
    Tse, K. Y.
    Lee, Y. M.
    Tse, S. M.
    Ho, F. P.
    Kwan, W. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] Predictors of lymphedema after axillary lymph node dissection for early breast cancer
    Fehr, MK
    Erismann, M
    Schneider, C
    Haller, U
    Fink, D
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2002, 62 (09) : 862 - 869
  • [4] Lymphedema following axillary lymph node dissection for breast cancer
    Sakorafas, George H.
    Peros, George
    Cataliotti, Luigi
    Vlastos, George
    SURGICAL ONCOLOGY-OXFORD, 2006, 15 (03): : 153 - 165
  • [5] Trends of axillary surgery in breast cancer patients with axillary lymph node metastasis: a comprehensive single-center retrospective study
    Kim, Yeon Jin
    Kim, Hye Jin
    Chung, Soo Yeon
    Lee, Se Kyung
    Chae, Byung Joo
    Yu, Jonghan
    Lee, Jeong Eon
    Kim, Seok Won
    Nam, Seok Jin
    Ryu, Jai Min
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2023, 105 (01) : 10 - 19
  • [6] Impact of neoadjuvant chemotherapy on breast cancer-related lymphedema after axillary lymph node dissection: a retrospective cohort study
    Miaomiao Jia
    Lihui Pan
    Haibo Yang
    Jinnan Gao
    Fan Guo
    Breast Cancer Research and Treatment, 2024, 204 : 223 - 235
  • [7] Impact of neoadjuvant chemotherapy on breast cancer-related lymphedema after axillary lymph node dissection: a retrospective cohort study
    Jia, Miaomiao
    Pan, Lihui
    Yang, Haibo
    Gao, Jinnan
    Guo, Fan
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 204 (02) : 223 - 235
  • [8] Breast-Cancer-Related Lymphedema (BCRL) After Axillary Reverse Mapping And Selective Dissection (ARM-SAD) Versus Axillary Lymph Node Dissection (ALND): Results Of A Single-Center Prospective Study
    Maccauro, M.
    Lorenzoni, A.
    Chisari, M.
    Aliberti, G.
    De Vivo, A.
    Caraceni, A.
    Maugeri, I.
    Sigari, C.
    Mariani, L.
    Mansi, D.
    Folli, S.
    Seregni, E.
    Gennaro, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S64 - S64
  • [9] A Cross-sectional Study Examining the Risk Factors Associated with Lymphedema and its Prevalence in Breast Cancer Patients after Level 3 Axillary Lymph Node Dissection
    Kibar, Sibel
    Dalyan Aras, Meltem
    Unsal Delialioglu, Sibel
    Koseoglu, Belma Fusun
    TURKIYE FIZIKSEL TIP VE REHABILITASYON DERGISI-TURKISH JOURNAL OF PHYSICAL MEDICINE AND REHABILITATION, 2015, 61 (01): : 36 - 44
  • [10] Patterns of Axillary Lymph Node Metastasis in Breast Cancer: A Prospective Single-Center Study
    Choi, Hee Jun
    Kum, Jae-Myung
    Ryu, Jai Min
    Kim, Isaac
    Nam, Seok Jin
    Yu, Jonghan
    Lee, Se Kyung
    Lee, Jeong Eon
    Kim, Seok Won
    JOURNAL OF BREAST CANCER, 2018, 21 (04) : 447 - 452